U.S. Health Agencies Recommend First Omicron Booster Shot | Time
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster | Nature Medicine
FDA advisors recommend using Covid omicron shots for all doses
Bivalent COVID-19 boosters may cut risk of severe disease by more than half | CIDRAP
FDA clears the way for additional bivalent boosters for certain vulnerable individuals | CNN
Updated COVID-19 booster targets subvariants responsible for 98% of cases today | Malheur County Health Department
ATAGI recommendations on use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine | Australian Government Department of Health and Aged Care
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health
Real-world data show new Covid boosters increase protection
County Center - Update: Buncombe County Providers Offering Booster Doses for Individuals Ages 5+
Moderna on X: "@GovCanHealth has authorized the use of our Omicron-targeting #bivalent COVID-19 booster #vaccine, mRNA-1273.214, as a booster dose for active immunization against #COVID19 in individuals 18 years of age and
Updated COVID booster tied to strong Omicron immune response | CIDRAP
The Updated COVID Boosters Could Have Been Better | MedPage Today
Durability of Bivalent Boosters against Omicron Subvariants | NEJM
COVID-19 Bivalent Boosters | Johns Hopkins | Bloomberg School of Public Health
Second Omicron Booster Authorized | MedPage Today
Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation - The Lancet Infectious Diseases
Monovalent and bivalent COVID boosters provide strong protection against severe outcomes in older adults
Effectiveness of Bivalent Boosters against Severe Omicron Infection | NEJM
Omicron Boosters Approved by CDC
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial -
Vaccines | Free Full-Text | Vaccine Confidence and Uptake of the Omicron Bivalent Booster in Tennessee: Implications for Vulnerable Populations
Vaccines and Boosters Offer Best Defense Against Omicron
The Omicron Booster: Your Questions Answered > News > Yale Medicine
